Reaction
Tongue Erythema reporting signals
As of the last recalculation, Tongue Erythema appears in 802 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is FELODIPINE EXTENDED-RELEASE TABLETS (PRR 30.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Felodipine Extended-Release Tablets | 13 | 30.1 | 30.1 |
| Felodipine | 13 | 30.1 | 30.1 |
| Cabozantinib | 35 | 19.7 | 19.7 |
| Fexofenadine | 12 | 19.1 | 19.1 |
| Alpelisib | 5 | 15.0 | 15.0 |
| Sunitinib Malate | 16 | 10.8 | 10.8 |
| Nirmatrelvir And Ritonavir | 21 | 10.3 | 10.3 |
| Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate | 15 | 9.6 | 9.6 |
| Rucaparib | 3 | 8.8 | 8.8 |
| Galcanezumab-Gnlm | 5 | 4.1 | 4.1 |